iX Biopharma is a listed, specialty pharmaceutical and nutraceutical company focusing on the development and commercialisation of therapies for diseases of the central nervous system using novel, patent-protected formulations for sublingual delivery. iX Biopharma’s pipeline of products under development includes Wafermine (ketamine wafer) and BnoX (buprenorphine wafer) for pain management. iX Biopharma’s drugs for the treatment of erectile dysfunction, Wafesil, a sublingual sildenafil wafer, and Silcap, have been registered in Australia. iX Biopharma has developed Xativa, the world’s first freeze-dried sublingual medicinal cannabis wafer. The Group’s nutraceuticals division, Entity Health Limited, is engaged in the development and commercialisation of nutraceutical products. Subsidiaries: iX Syrinx ( https://www.ixsyrinx.com ) Entity health ( https://www.entity-health.com )
View Top Employees from iX Biopharma| Website | https://www.ixbiopharma.com/ |
| Revenue | $4 million |
| Employees | 13 (11 on RocketReach) |
| Founded | 2000 |
| Address | 80 Robinson Rd 02-00, Singapore, Central Singapore, SG |
| Phone | (656) 235-2270 |
| Fax | (656) 235-2170 |
| Technologies |
JavaScript,
HTML,
PHP
+13 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Drug Stores & Pharmacies, Drug Discovery, Retail, Pharmaceuticals |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular iX Biopharma employee's phone or email?
iX Biopharma Questions
The iX Biopharma annual revenue was $4 million in 2024.
Janakan Krishnarajah is the Chief Operating Officer and Chief Medical Officer of iX Biopharma.
11 people are employed at iX Biopharma.
iX Biopharma is based in Singapore, Central Singapore.
The NAICS codes for iX Biopharma are [3254, 32541, 32, 325].
The SIC codes for iX Biopharma are [283, 28].
Top iX Biopharma Employees
-
3
-
21
-
33
-
2
Related Companies
